Application 761177

Type
BLA
Sponsor
ACENDIS PHARMA ENDOCRINOLOGY DIV A/S

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761177Skytrofalonapegsomatropin-tcgd351(a)Rx2026-07-01

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001SKYTROFALONAPEGSOMATROPIN-TCGDINJECTABLE;INJECTION3MGNoNo
002SKYTROFALONAPEGSOMATROPIN-TCGDINJECTABLE;INJECTION3.6MGNoNo
003SKYTROFALONAPEGSOMATROPIN-TCGDINJECTABLE;INJECTION4.3MGNoNo
004SKYTROFALONAPEGSOMATROPIN-TCGDINJECTABLE;INJECTION5.2MGNoNo
005SKYTROFALONAPEGSOMATROPIN-TCGDINJECTABLE;INJECTION6.3MGNoNo
006SKYTROFALONAPEGSOMATROPIN-TCGDINJECTABLE;INJECTION7.6MGNoNo
007SKYTROFALONAPEGSOMATROPIN-TCGDINJECTABLE;INJECTION9.1MGNoNo
008SKYTROFALONAPEGSOMATROPIN-TCGDINJECTABLE;INJECTION11MGNoNo
009SKYTROFALONAPEGSOMATROPIN-TCGDINJECTABLE;INJECTION13.3MGNoNo

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SkytrofaLONAPEGSOMATROPIN-TCGDAscendis Pharma Endocrinology, Inc.9229f871-bc61-4ddc-8122-d126d40e36ac2026-07-23Warnings, Adverse reactionsExact identifier
application number: BLA761177
ndc (product): 73362-008
ndc (product): 73362-010
ndc (product): 73362-011
ndc (product): 73362-006
ndc (product): 73362-003
ndc (product): 73362-009
ndc (product): 73362-007
ndc (product): 73362-005
ndc (product): 73362-004

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 45 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
73362-003SkytrofaLonapegsomatropin-tcgdAscendis Pharma Endocrinology, Inc.BLACurrent
73362-003SkytrofaLonapegsomatropin-tcgdAscendis Pharma Endocrinology, Inc.BLACurrent
73362-003SkytrofaLonapegsomatropin-tcgdAscendis Pharma Endocrinology, Inc.BLACurrent
73362-003SkytrofaLonapegsomatropin-tcgdAscendis Pharma, Inc.BLACurrent
73362-003SkytrofaLonapegsomatropin-tcgdAscendis Pharma Endocrinology, Inc.BLACurrent
73362-004SkytrofaLonapegsomatropin-tcgdAscendis Pharma Endocrinology, Inc.BLACurrent
73362-004SkytrofaLonapegsomatropin-tcgdAscendis Pharma Endocrinology, Inc.BLACurrent
73362-004SkytrofaLonapegsomatropin-tcgdAscendis Pharma Endocrinology, Inc.BLACurrent
73362-004SkytrofaLonapegsomatropin-tcgdAscendis Pharma, Inc.BLACurrent
73362-004SkytrofaLonapegsomatropin-tcgdAscendis Pharma Endocrinology, Inc.BLACurrent
73362-005SkytrofaLonapegsomatropin-tcgdAscendis Pharma Endocrinology, Inc.BLACurrent
73362-005SkytrofaLonapegsomatropin-tcgdAscendis Pharma Endocrinology, Inc.BLACurrent
73362-005SkytrofaLonapegsomatropin-tcgdAscendis Pharma Endocrinology, Inc.BLACurrent
73362-005SkytrofaLonapegsomatropin-tcgdAscendis Pharma, Inc.BLACurrent
73362-005SkytrofaLonapegsomatropin-tcgdAscendis Pharma Endocrinology, Inc.BLACurrent
73362-006SkytrofaLonapegsomatropin-tcgdAscendis Pharma Endocrinology, Inc.BLACurrent
73362-006SkytrofaLonapegsomatropin-tcgdAscendis Pharma Endocrinology, Inc.BLACurrent
73362-006SkytrofaLonapegsomatropin-tcgdAscendis Pharma Endocrinology, Inc.BLACurrent
73362-006SkytrofaLonapegsomatropin-tcgdAscendis Pharma, Inc.BLACurrent
73362-006SkytrofaLonapegsomatropin-tcgdAscendis Pharma Endocrinology, Inc.BLACurrent
73362-007SkytrofaLonapegsomatropin-tcgdAscendis Pharma Endocrinology, Inc.BLACurrent
73362-007SkytrofaLonapegsomatropin-tcgdAscendis Pharma Endocrinology, Inc.BLACurrent
73362-007SkytrofaLonapegsomatropin-tcgdAscendis Pharma Endocrinology, Inc.BLACurrent
73362-007SkytrofaLonapegsomatropin-tcgdAscendis Pharma, Inc.BLACurrent
73362-007SkytrofaLonapegsomatropin-tcgdAscendis Pharma Endocrinology, Inc.BLACurrent
73362-008SkytrofaLonapegsomatropin-tcgdAscendis Pharma Endocrinology, Inc.BLACurrent
73362-008SkytrofaLonapegsomatropin-tcgdAscendis Pharma Endocrinology, Inc.BLACurrent
73362-008SkytrofaLonapegsomatropin-tcgdAscendis Pharma Endocrinology, Inc.BLACurrent
73362-008SkytrofaLonapegsomatropin-tcgdAscendis Pharma, Inc.BLACurrent
73362-008SkytrofaLonapegsomatropin-tcgdAscendis Pharma Endocrinology, Inc.BLACurrent
73362-009SkytrofaLonapegsomatropin-tcgdAscendis Pharma Endocrinology, Inc.BLACurrent
73362-009SkytrofaLonapegsomatropin-tcgdAscendis Pharma Endocrinology, Inc.BLACurrent
73362-009SkytrofaLonapegsomatropin-tcgdAscendis Pharma Endocrinology, Inc.BLACurrent
73362-009SkytrofaLonapegsomatropin-tcgdAscendis Pharma, Inc.BLACurrent
73362-009SkytrofaLonapegsomatropin-tcgdAscendis Pharma Endocrinology, Inc.BLACurrent
73362-010SkytrofaLonapegsomatropin-tcgdAscendis Pharma Endocrinology, Inc.BLACurrent
73362-010SkytrofaLonapegsomatropin-tcgdAscendis Pharma Endocrinology, Inc.BLACurrent
73362-010SkytrofaLonapegsomatropin-tcgdAscendis Pharma Endocrinology, Inc.BLACurrent
73362-010SkytrofaLonapegsomatropin-tcgdAscendis Pharma, Inc.BLACurrent
73362-010SkytrofaLonapegsomatropin-tcgdAscendis Pharma Endocrinology, Inc.BLACurrent
73362-011SkytrofaLonapegsomatropin-tcgdAscendis Pharma Endocrinology, Inc.BLACurrent
73362-011SkytrofaLonapegsomatropin-tcgdAscendis Pharma Endocrinology, Inc.BLACurrent
73362-011SkytrofaLonapegsomatropin-tcgdAscendis Pharma Endocrinology, Inc.BLACurrent
73362-011SkytrofaLonapegsomatropin-tcgdAscendis Pharma, Inc.BLACurrent
73362-011SkytrofaLonapegsomatropin-tcgdAscendis Pharma Endocrinology, Inc.BLACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
82965SUPPL 2025-07-28
82955SUPPL 2025-07-28
82796SUPPL 2025-07-11
82779SUPPL 2025-07-11
72457SUPPL2022-10-24
72438SUPPL2022-10-21
68746ORIG2021-09-24
68474ORIG2021-08-27
68466ORIG2021-08-25